- Home
- EBF vs PRTA Comparison
EBF vs PRTA Comparison
Compare EBF & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- PRTA
- Stock Information
- Founded
- EBF 1909
- PRTA 2012
- Country
- EBF United States
- PRTA Ireland
- Employees
- EBF N/A
- PRTA N/A
- Industry
- EBF Office Equipment/Supplies/Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- EBF Consumer Discretionary
- PRTA Health Care
- Exchange
- EBF Nasdaq
- PRTA Nasdaq
- Market Cap
- EBF 448.8M
- PRTA 472.1M
- IPO Year
- EBF N/A
- PRTA N/A
- Fundamental
- Price
- EBF $16.96
- PRTA $10.45
- Analyst Decision
- EBF
- PRTA Buy
- Analyst Count
- EBF 0
- PRTA 9
- Target Price
- EBF N/A
- PRTA $17.71
- AVG Volume (30 Days)
- EBF 242.5K
- PRTA 567.7K
- Earning Date
- EBF 12-22-2025
- PRTA 11-06-2025
- Dividend Yield
- EBF 5.89%
- PRTA N/A
- EPS Growth
- EBF 3.59
- PRTA N/A
- EPS
- EBF 1.63
- PRTA N/A
- Revenue
- EBF $388,344,000.00
- PRTA $11,786,000.00
- Revenue This Year
- EBF $0.96
- PRTA N/A
- Revenue Next Year
- EBF N/A
- PRTA $672.02
- P/E Ratio
- EBF $10.43
- PRTA N/A
- Revenue Growth
- EBF N/A
- PRTA N/A
- 52 Week Low
- EBF $16.30
- PRTA $4.32
- 52 Week High
- EBF $22.29
- PRTA $18.65
- Technical
- Relative Strength Index (RSI)
- EBF 46.82
- PRTA 56.63
- Support Level
- EBF $16.86
- PRTA $10.02
- Resistance Level
- EBF $17.27
- PRTA $11.17
- Average True Range (ATR)
- EBF 0.38
- PRTA 0.56
- MACD
- EBF 0.07
- PRTA -0.07
- Stochastic Oscillator
- EBF 63.91
- PRTA 37.37
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.